Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas

References

1. 1.↵
   2. Cohen AL,
   3. Holmen SL,
   4. Colman H

   . IDH1 and IDH2 mutations in gliomas. Curr Neurol Neurosci Rep 2013;13:345 doi:10.1007/s11910-013-0345-4 pmid:23532369

   CrossRefPubMed
2. 2.↵
   2. Nobusawa S,
   3. Watanabe T,
   4. Kleihues P, et al

   . IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 2009;15:6002–07 doi:10.1158/1078-0432.CCR-09-0715 pmid:19755387

   Abstract/FREE Full Text
3. 3.↵
   2. Yan H,
   3. Parsons DW,
   4. Jin G, et al

   . IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009;360:765–73 doi:10.1056/NEJMoa0808710 pmid:19228619

   CrossRefPubMedWeb of Science
4. 4.↵
   2. van den Bent MJ,
   3. Brandes AA,
   4. Taphoorn MJ, et al

   . Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 2013;31:344–50 doi:10.1200/JCO.2012.43.2229 pmid:23071237

   Abstract/FREE Full Text
5. 5.↵
   2. Cairncross G,
   3. Wang M,
   4. Shaw E, et al

   . Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 2013;31:337–43 doi:10.1200/JCO.2012.43.2674 pmid:23071247

   Abstract/FREE Full Text
6. 6.↵
   2. Hegi ME,
   3. Diserens AC,
   4. Gorlia T, et al

   . MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352:997–1003 doi:10.1056/NEJMoa043331 pmid:15758010

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Louis DN,
   3. Perry A,
   4. Reifenberger G, et al

   . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131:803–20 doi:10.1007/s00401-016-1545-1 pmid:27157931

   CrossRefPubMed
8. 8.↵
   2. Gill BJ,
   3. Pisapia DJ,
   4. Malone HR, et al

   . MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma. Proc Natl Acad Sci U S A 2014;111:12550–55 doi:10.1073/pnas.1405839111 pmid:25114226

   Abstract/FREE Full Text
9. 9.↵
   2. Belden CJ,
   3. Valdes PA,
   4. Ran C, et al

   . Genetics of glioblastoma: a window into its imaging and histopathologic variability. Radiographics 2011;31:1717–40 doi:10.1148/rg.316115512 pmid:21997991

   CrossRefPubMedWeb of Science
10. 10.↵
    National Cancer Institute. Wiki for the VASARI feature set. https://wiki.nci.nih.gov/display/CIP/VASARI. Accessed August 30, 2017
11. 11.↵
    2. LeCun Y,
    3. Bengio Y,
    4. Hinton G

    . Deep learning. Nature 2015;521:436–44 doi:10.1038/nature14539 pmid:26017442

    CrossRefPubMed
12. 12.↵
    2. Clark K,
    3. Vendt B,
    4. Smith K, et al

    . The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J Digit Imaging 2013;26:1045–57 doi:10.1007/s10278-013-9622-7 pmid:23884657

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Ceccarelli M,
    3. Barthel FP,
    4. Malta TM, et al

    . Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 2016;164:550–63 doi:10.1016/j.cell.2015.12.028 pmid:26824661

    CrossRefPubMed
14. 14.↵
    2. Jenkinson M,
    3. Smith S

    . A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143–56 doi:10.1016/S1361-8415(01)00036-6 pmid:11516708

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Jenkinson M,
    3. Bannister P,
    4. Brady M, et al

    . Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825–41 doi:10.1006/nimg.2002.1132 pmid:12377157

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Crimi A,
    2. Menze B,
    3. Maier O, et al.

    2. Chang PD

    . Fully convolutional deep residual neural networks for brain tumor segmentation. In: Crimi A, Menze B, Maier O, et al., eds. Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries: Second International Workshop, BrainLes 2016, with the Challenges on BRATS, ISLES and mTOP 2016, Held in Conjunction with MICCAI 2016, Athens, Greece, October 17, 2016, Revised Selected Papers. Cham: Springer-Verlag International Publishing; 2016:108–18
17. 17.↵
    1. Arbib MA

    2. LeCun Y,
    3. Bengio Y

    . Convolutional networks for images, speech, and time-series. In: Arbib MA, ed. The Handbook of Brain Theory and Neural Networks. Cambridge: MIT Press; 1998:255–58
18. 18.↵
    2. Gorlia T,
    3. van den Bent MJ,
    4. Hegi ME, et al

    . Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981–22981/CE.3. Lancet Oncol 2008;9:29–38 doi:10.1016/S1470-2045(07)70384-4 pmid:18082451

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Ryu YJ,
    3. Choi SH,
    4. Park SJ, et al

    . Glioma: application of whole-tumor texture analysis of diffusion-weighted imaging for the evaluation of tumor heterogeneity. PLoS One 2014;9:e108335 doi:10.1371/journal.pone.0108335 pmid:25268588

    CrossRefPubMed
20. 20.↵
    2. Drabycz S,
    3. Roldán G,
    4. de Robles P, et al

    . An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Neuroimage 2010;49:1398–405 doi:10.1016/j.neuroimage.2009.09.049 pmid:19796694

    CrossRefPubMed
21. 21.↵
    2. Kanas VG,
    3. Zacharaki EI,
    4. Thomas GA, et al

    . Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma. Comput Methods Programs Biomed 2017;140:249–57 doi:10.1016/j.cmpb.2016.12.018 pmid:28254081

    CrossRefPubMed
22. 22.↵
    2. Kassner A,
    3. Thornhill RE

    . Texture analysis: a review of neurologic MR imaging applications. AJNR Am J Neuroradiol 2010;31:809–16 doi:10.3174/ajnr.A2061 pmid:20395383

    Abstract/FREE Full Text
23. 23.↵
    2. Simonyan K,
    3. Vedaldi A,
    4. Zisserman A

    . Deep inside convolutional networks: visualising image classification models and saliency maps. CoRR 2013;abs/1312.6034. https://arxiv.org/abs/1312.6034. Accessed August 30, 2017
24. 24.↵
    2. He K,
    3. Zhang X,
    4. Ren S, et al

    . Delving deep into rectifiers: surpassing human-level performance on ImageNet classification. In: Proceedings of the IEEE International Conference on Computer Vision, Santiago, Chili. December 7–13, 2015:1026–34
25. 25.↵
    2. He K,
    3. Zhang X,
    4. Ren S, et al

    . Deep residual learning for image recognition. CoRR 2015;abs/1512.03385. https://arxiv.org/abs/1512.03385. Accessed August 30, 2017
26. 26.↵
    2. Krizhevsky A,
    3. Sutskever I,
    4. Hinton G

    . ImageNet classification with deep convolutional neural networks. https://www.nvidia.cn/content/tesla/pdf/machine-learning/imagenet-classification-with-deep-convolutional-nn.pdf. Accessed August 30, 2017
27. 27.↵
    2. Setio AA,
    3. Ciompi F,
    4. Litjens G, et al

    . Pulmonary nodule detection in CT images: false positive reduction using multi-view convolutional networks. IEEE Trans Med Imaging 2016;35:1160–69 doi:10.1109/TMI.2016.2536809 pmid:26955024

    CrossRefPubMed
28. 28.↵
    2. Roth HR,
    3. Lu L,
    4. Liu J, et al

    . Improving computer-aided detection using convolutional neural networks and random view aggregation. IEEE Trans Med Imaging 2016;35:1170–81 doi:10.1109/TMI.2015.2482920 pmid:26441412

    CrossRefPubMed
29. 29.↵
    2. He K,
    3. Zhang X,
    4. Ren S, et al

    . Deep residual learning for image recognition. In: Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition, Las Vegas, Nevada. June 27–30, 2016
30. 30.↵
    2. Lakhani P,
    3. Sundaram B

    . Deep learning at chest radiography: automated classification of pulmonary tuberculosis by using convolutional neural networks. Radiology 2017;284:574–82 doi:10.1148/radiol.2017162326 pmid:28436741

    CrossRefPubMed
31. 31.↵
    2. Pande T,
    3. Cohen C,
    4. Pai M, et al

    . Computer-aided detection of pulmonary tuberculosis on digital chest radiographs: a systematic review. Int J Tuberc Lung Dis 2016;20:1226–30 doi:10.5588/ijtld.15.0926 pmid:27510250

    CrossRefPubMed
32. 32.↵
    2. Chang PD,
    3. Malone HR,
    4. Bowden SG, et al

    . A multiparametric model for mapping cellularity in glioblastoma using radiographically localized biopsies. AJNR Am J Neuroradiol 2017;38:890–98 doi:10.3174/ajnr.A5112 pmid:28255030

    Abstract/FREE Full Text
33. 33.↵
    2. Zhang W,
    3. Li R,
    4. Deng H, et al

    . Deep convolutional neural networks for multi-modality isointense infant brain image segmentation. Neuroimage 2015;108:214–24 doi:10.1016/j.neuroimage.2014.12.061 pmid:25562829

    CrossRefPubMed
34. 34.↵
    2. Chang K,
    3. Bai HX,
    4. Zhou H, et al

    . Residual convolutional neural network for the determination of IDH status in low- and high-grade gliomas from MR imaging. Clin Cancer Res 2018;24:1073–81 doi:10.1158/1078-0432.CCR-17-2236 pmid:29167275

    Abstract/FREE Full Text
35. 35.↵
    2. Korfiatis P,
    3. Kline TL,
    4. Lachance DH, et al

    . Residual deep convolutional neural network predicts MGMT methylation status. J Digit Imaging 2017;30:622–28 doi:10.1007/s10278-017-0009-z pmid:28785873

    CrossRefPubMed
36. 36.↵
    1. Fleet D,
    2. Pajdla T,
    3. Schiele B, et al.

    2. Zeiler MD,
    3. Fergus R

    . Visualizing and understanding convolutional networks. In: Fleet D, Pajdla T, Schiele B, et al., eds. Proceedings of the European Conference on Computer Vision, Zurich, Switzerland. September 6–12, 2014
37. 37.↵
    2. Carrillo JA,
    3. Lai A,
    4. Nghiemphu PL, et al

    . Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma. AJNR Am J Neuroradiol 2012;33:1349–55 doi:10.3174/ajnr.A2950 pmid:22322613

    Abstract/FREE Full Text
38. 38.↵
    2. Qi S,
    3. Yu L,
    4. Li H, et al

    . Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms. Oncol Lett 2014;7:1895–902 doi:10.3892/ol.2014.2013 pmid:24932255

    CrossRefPubMed
39. 39.↵
    2. Sonoda Y,
    3. Shibahara I,
    4. Kawaguchi T, et al

    . Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas. Brain Tumor Pathol 2015;32:99–104 doi:10.1007/s10014-014-0211-3 pmid:25537428

    CrossRefPubMed
40. 40.↵
    2. Metellus P,
    3. Coulibaly B,
    4. Colin C, et al

    . Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis. Acta Neuropathol 2010;120:719–29 doi:10.1007/s00401-010-0777-8 pmid:21080178

    CrossRefPubMedWeb of Science
41. 41.↵
    2. Xiong J,
    3. Tan W,
    4. Wen J, et al

    . Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours. Eur Radiol 2016;26:1705–15 doi:10.1007/s00330-015-4025-4 pmid:26396108

    CrossRefPubMed
42. 42.↵
    2. Johnson DR,
    3. Diehn FE,
    4. Giannini C, et al

    . Genetically defined oligodendroglioma is characterized by indistinct tumor borders at MRI. AJNR Am J Neuroradiol 2017;38:678–84 doi:10.3174/ajnr.A5070 pmid:28126746

    Abstract/FREE Full Text
43. 43.↵
    2. Ellingson BM,
    3. Lai A,
    4. Harris RJ, et al

    . Probabilistic radiographic atlas of glioblastoma phenotypes. AJNR Am J Neuroradiol 2013;34:533–40 doi:10.3174/ajnr.A3253 pmid:22997168

    Abstract/FREE Full Text
44. 44.↵
    2. Paldor I,
    3. Pearce FC,
    4. Drummond KJ, et al

    . Frontal glioblastoma multiforme may be biologically distinct from non-frontal and multilobar tumors. J Clin Neurosci 2016;34:128–32 doi:10.1016/j.jocn.2016.05.017 pmid:27593971

    CrossRefPubMed
45. 45.↵
    2. Moon WJ,
    3. Choi JW,
    4. Roh HG, et al

    . Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging. Neuroradiology 2012;54:555–63 doi:10.1007/s00234-011-0947-y pmid:21833736

    CrossRefPubMed
46. 46.↵
    2. Eoli M,
    3. Menghi F,
    4. Bruzzone MG, et al

    . Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Clin Cancer Res 2007;13:2606–13 doi:10.1158/1078-0432.CCR-06-2184 pmid:17473190

    Abstract/FREE Full Text